Gara Jalqabaatti › Degenereshinii Makulaarii › Texas › Cypress
Qorannoo klinikaalii Degenereshinii Makulaarii Cypress, TX keessatti
Qorannoo 4 Degenereshinii Makulaarii f Cypress fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Namoota walitti qabaa jiraSadarkaa 3
- Retina Consultants of Texas, Katy · Miili 15 fagaatti
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Namoota walitti qabaa jiraSadarkaa 2
- Retina Consultants of Texas, Katy · Miili 15 fagaatti
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Namoota walitti qabaa jiraQorannoo ilaalaa
- Retina Consultants of Texas, Katy · Miili 15 fagaatti
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Namoota walitti qabaa jiraSadarkaa 2/3
- Retina Consultants of Texas, Katy · Miili 15 fagaatti
Qorannoo Degenereshinii Makulaarii magaalota biroo keessatti
- Dallas, TXQorannoo 13
- Erie, PAQorannoo 10
- The Woodlands, TXQorannoo 9
- Reno, NVQorannoo 8
- Hagerstown, MDQorannoo 8
- Sacramento, CAQorannoo 8
- Fort Worth, TXQorannoo 7
- Cleveland, OHQorannoo 7
- Salt Lake City, UTQorannoo 7
- Houston, TXQorannoo 7
- Carmel, INQorannoo 7
- Austin, TXQorannoo 7
Qorannoo biroo Cypress keessatti
- Dhukkubaa AlzheimerQorannoo 7
- Sukkaraa Gosa 2Qorannoo 4
- COPDQorannoo 4
- Haala Sochii HafuuraQorannoo 3
- Sindroomii SjogrenQorannoo 3
- Cufama OnneeQorannoo 3
- Saree OljooQorannoo 3
- AasthmaQorannoo 3
- Edema MakulaariiQorannoo 3
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.